Spots Global Cancer Trial Database for pharmacokinetics (pk)
Every month we try and update this database with for pharmacokinetics (pk) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT02705469 | Metastatic Cast... | ZEN003694 | 18 Years - | Zenith Epigenetics | |
Study to Describe the Interaction Between Tazemetostat and Itraconazole and Between Tazemetostat and Rifampin in Participants With Advanced Cancer | NCT04537715 | All Malignancie... Advanced Malign... Hematologic Mal... Solid Tumor Follicular Lymp... Non-Hodgkin Lym... Diffuse Large B... Epithelioid Sar... Synovial Sarcom... Renal Medullary... Mesothelioma Rhabdoid Tumor | Tazemetostat Itraconazole Tazemetostat Rifampin | 18 Years - | Ipsen | |
Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) | NCT00444015 | Non-Small-Cell ... | Erlotinib in co... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |